CD4 and neoplasm: In addition to imaging, the efficacy of immunotherapy pembrolizumab in the presented case was also demonstrated by the post-treatment increase in the infiltration of CD8 + T cells within the tumour and the decreased CD4 +/CD8 + ratio.